Helicobacter pylori lipopolysaccharide hinders polymorphonuclear leucocyte apoptosis

Laboratory Investigation; a Journal of Technical Methods and Pathology
V HofmanP Hofman

Abstract

A prominent histologic feature of Helicobacter pylori infection is a dense infiltration of polymorphonuclear leukocytes (PMNL) in gastric mucosa. H. pylori lipopolysaccharide (LPS) has been recognized as a primary virulence factor evoking acute mucosal inflammatory reaction. Previous works have shown that H. pylori LPS immunologic activities are lower than those of enterobacterial LPS. However, the effect of H. pylori LPS on spontaneous PMNL apoptosis, and mechanisms by which this H. pylori LPS may promote PMNL survival remain to be established. In this study, we investigated, by both morphologic and biochemical approaches, the action of H. pylori LPS on PMNL apoptosis in vitro, using broth culture filtrates (BCF) of H. pylori strains with different genotypes. We found that BCF from H. pylori caused a significant delay in spontaneous PMNL apoptosis and this delay was independent of the VacA, cag pathogenicity island and urease status. We demonstrated that LPS in BCF is responsible for this effect because it was abrogated by the LPS antagonist B287 (a synthetic analog of Rhodobactersphaeroides lipid A). Moreover, BCF from H. pylori induced P42/44MAP kinase activation in PMNL. Similar results were obtained with BCF of an Escheric...Continue Reading

References

Sep 1, 1992·Infection and Immunity·G I Pérez-PérezM J Blaser
Apr 1, 1992·Infection and Immunity·A MuotialaA P Moran
Apr 1, 1991·Infection and Immunity·B Brunkhorst, R Niederman
May 1, 1990·Journal of Clinical Microbiology·G GeisW Opferkuch
Jul 3, 1980·Nature·A H GordonM R Young
Jun 1, 1995·Infection and Immunity·D J EvansP R Kvietys
Feb 1, 1995·FEMS Immunology and Medical Microbiology·A P Moran
Jul 1, 1994·The Journal of Infectious Diseases·H NielsenA P Moran
Apr 1, 1996·Molecular Microbiology·T L Cover
Jul 1, 1996·The American Journal of Physiology·P HofmanJ L Madara
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·S CensiniA Covacci
May 1, 1997·European Journal of Gastroenterology & Hepatology·K MayoF Mégraud
Aug 15, 1997·The Journal of Clinical Investigation·M J Blaser
Nov 14, 1997·Infection and Immunity·W L Beatty, P J Sansonetti
Oct 6, 1997·Cellular Signalling·A PaulR Plevin
May 29, 1998·Infection and Immunity·P CaoT L Cover
Mar 20, 1999·Infection and Immunity·B Leblebicioglu, J Walters
May 20, 1999·The Journal of Cell Biology·W L BeattyJ P Gorvel
May 21, 1999·Science·A CovacciR Rappuoli
Sep 25, 1999·Infection and Immunity·W SchrawT L Cover
Feb 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·J B KleinK R McLeish

❮ Previous
Next ❯

Citations

Dec 11, 2008·Immunologic Research·Adam D Kennedy, Frank R DeLeo
Sep 28, 2016·World Journal of Gastroenterology : WJG·Eliza MnichMagdalena Chmiela

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Caspases in Metabolic Diseases

Caspases, the family of cysteine proteases are involved in programmed cell death, but their role in metabolic diseases, inflammation and immunity has been of interested. Discover the latest research on caspases in metabolic diseases here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis